Putnam Investments’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $521M | Buy |
|
|||||
|
2023
Q3 | $501M | Sell |
|
|||||
|
2023
Q2 | $538M | Buy |
|
|||||
|
2023
Q1 | $518M | Buy |
|
|||||
|
2022
Q4 | $505M | Buy |
|
|||||
|
2022
Q3 | $403M | Sell |
|
|||||
|
2022
Q2 | $485M | Buy |
|
|||||
|
2022
Q1 | $485M | Buy |
|
|||||
|
2021
Q4 | $415M | Buy |
|
|||||
|
2021
Q3 | $424M | Buy |
|
|||||
|
2021
Q2 | $282M | Buy |
|
|||||
|
2021
Q1 | $233M | Buy |
|
|||||
|
2020
Q4 | $224M | Buy |
|
|||||
|
2020
Q3 | $232M | Buy |
|
|||||
|
2020
Q2 | $222M | Sell |
|
|||||
|
2020
Q1 | $213M | Buy |
|
|||||
|
2019
Q4 | $234M | Buy |
|
|||||
|
2019
Q3 | $207M | Buy |
|
|||||
|
2019
Q2 | $189M | Buy |
|
|||||
|
2019
Q1 | $185M | Buy |
|
|||||
|
2018
Q4 | $172M | Buy |
|
|||||
|
2018
Q3 | $175M | Buy |
|
|||||
|
2018
Q2 | $154M | Sell |
|
|||||
|
2018
Q1 | $154M | Sell |
|
|||||
|
2017
Q4 | $153M | Buy |
|
|||||
|
2017
Q3 | $147M | Sell |
|
|||||
|
2017
Q2 | $151M | Buy |
|
|||||
|
2017
Q1 | $134M | Buy |
|
|||||
|
2016
Q4 | $118M | Sell |
|
|||||
|
2016
Q3 | $143M | Buy |
|
|||||
|
2016
Q2 | $131M | Buy |
|
|||||
|
2016
Q1 | $122M | Sell |
|
|||||
|
2015
Q4 | $151M | Sell |
|
|||||
|
2015
Q3 | $142M | Sell |
|
|||||
|
2015
Q2 | $142M | Sell |
|
|||||
|
2015
Q1 | $163M | Sell |
|
|||||
|
2014
Q4 | $198M | Buy |
|
|||||
|
2014
Q3 | $197M | Buy |
|
|||||
|
2014
Q2 | $173M | Sell |
|
|||||
|
2014
Q1 | $159M | Buy |
|
|||||
|
2013
Q4 | $139M | Buy |
|
|||||
|
2013
Q3 | $114M | Buy |
|
|||||
|
2013
Q2 | $23.9M | Buy |
|